Agrivero Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.48 M
- Revenue Growth 142.42%
- Profit Growth 494.56%
- Ebitda 948.40%
- Net Worth 154.92%
- Total Assets 22.39%
About Agrivero Biotech
Agrivero Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 March 2021 (Three years and ten months 26 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.48 M.
Suresh Jaiswal, Amar Singh, and Babita Jaiswal serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01100TG2021PTC149624
-
Company No.
149624
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Mar 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Agrivero Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Jaiswal
|
Director | 15-Mar-2021 | Current |
|
Amar Singh
|
Director | Current | |
|
Babita Jaiswal
|
Director | 10-May-2022 | Current |
Financial Performance of Agrivero Biotech.
Agrivero Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 142.42% increase. The company also saw a substantial improvement in profitability, with a 494.56% increase in profit. The company's net worth Soared by an impressive increase of 154.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agrivero Biotech?
In 2023, Agrivero Biotech had a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ss Vinayakam Medicare Private LimitedSuresh Jaiswal is a mutual person
Charges (Loans)
₹4.48 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.36 Cr
- Others : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jan 2024 | Axis Bank Limited | ₹3.61 M | Open |
| 16 Jan 2024 | Others | ₹0.87 M | Open |
How Many Employees Work at Agrivero Biotech?
Agrivero Biotech has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agrivero Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agrivero Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
